Search for: "In the Interest of MDS" Results 1581 - 1600 of 2,863
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 Apr 2013, 2:52 am by Howard Iken
Others may immediately be interested in knowing if they’ll have to switch schools or who will take them to basketball practice. [read post]
10 Apr 2013, 7:44 am by Rahul Bhagnari, ACLU
James Evans, MD, PhD is the Bryson Distinguished Professor of Genetics and Medicine at the University of North Carolina Chapel Hill School of Medicine. [read post]
10 Apr 2013, 7:44 am by Rahul Bhagnari, ACLU
James Evans, MD, PhD is the Bryson Distinguished Professor of Genetics and Medicine at the University of North Carolina Chapel Hill School of Medicine. [read post]
8 Apr 2013, 4:00 am by Sean Hocking
In the meantime over at House of Butter we've reported the odd mildly interesting story. [read post]
17 Mar 2013, 8:32 am by Howard Friedman
The court gave defendants 30 days to file a second motion for summary judgment dealing with compelling interests and least restrictive means.In Scott v. [read post]
4 Mar 2013, 7:37 am by Joanna Herzik
We've found that every Texas lawyer has an interesting story. [read post]
3 Mar 2013, 11:59 am by Howard Friedman
LEXIS 22722 (MD GA, Feb. 20, 2013), a Georgia federal district court adopted a magistrate's recommendation (2013 U.S. [read post]
28 Feb 2013, 8:18 am by Raffaela Wakeman
It is scheduled to hold a public meeting and workshop on April 3rd out at its headquarters in Gaithersburg, MD. [read post]
27 Feb 2013, 3:44 am by Broc Romanek
Forward-Looking Disclosures and the 'Dividing Line' Between MD&A and Footnotes Beswick noted that in the past few years, the FASB has been working on three projects relating to disclosures: - Going concern - Liquidity and interest rate disclosures - Disclosure framework One thing the FASB has received feedback on, said Beswick, is an apparent "increasing frequency of frequency of things traditionally housed in MD&A, and moving them to disclosures." [read post]
25 Feb 2013, 2:33 pm by Tom Lamb
During that meeting, panel chair Wyndham Wilson, MD, PhD, chief of the lymphoma division at the National Cancer Institute in Bethesda, Md., said it appeared that [Omontys (peginesatide)] "doesn't have any safety signals." [read post]
25 Feb 2013, 7:37 am by Jerri Lynn Ward, J.D.
The federal government has so far not been interested in allowing that approach. [read post]
19 Feb 2013, 12:57 pm by Kathryn Fenderson Scott
Perhaps when the Florida Legislature enacted the new PIP law they believed that medical doctors (M.D.s) would be interested in treating auto accident cases, in light of the fact that the legislature  has required treatment by an MD, Do, or Dentist as a prerequisite to obtaining the full PIP benefits. [read post]